MedPath

Effects of antithrombotic drugs on thrombosis and bleeding risk in patients undergoing thoracic surgery

Not Applicable
Completed
Conditions
bleeding
Blood - Other blood disorders
Blood - Clotting disorders
thrombosis
Registration Number
ACTRN12619001417178
Lead Sponsor
Ayten Saracoglu
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

Cardiac patients over 18 years of age who will undergo open thoracic surgery or thoracoscopy and who use anticoagulants will be included in the study.

Exclusion Criteria

Patients with emergency surgery, patients under 18 years of age, patients with known bleeding disorder, patients with renal insufficiency, hepatic failure or congestive heart failure will be excluded from the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
upper extremity Deep Vein Thrombosis is followed and recorded after surgery by anesthesiologist.[48 hours after surgery]
Secondary Outcome Measures
NameTimeMethod
amount of hemorrhage checked from patients' blood sample by anesthesiologist.[48 hours after surgery]
© Copyright 2025. All Rights Reserved by MedPath